Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study (Q35124116)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study |
scientific article |
Statements
1 reference
Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study (English)
1 reference
Sigrid K Brækkan
1 reference
Hilde Jensvoll
1 reference
Kristine Blix
1 reference
John-Bjarne Hansen
1 reference
18 March 2014
1 reference
1 reference
9
1 reference
3
1 reference
e92011
1 reference
18 March 2014
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference